Why Glaukos Corp’s (GKOS) Stock Is Up 6.34% (2024)

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Glaukos Corp before investing.

In this article, we go over a few key elements for understanding Glaukos Corp’s stock price such as:

Before we jump into Glaukos Corp’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. It develops novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders and retinal disease. Its product candidates include Micro-Invasive Glaucoma Surgery products that involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma and procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time. Its products include transdermal pharmaceuticals that are applied to the eyelid and designed to treat glaucoma, dry eye, presbyopia and other ocular surface diseases and disorders and micro-invasive, bio-erodible sustained release drug delivery implants to improve the vision of patients.

Want to learn more about Glaukos Corp’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Glaukos Corp.

As of September 19, 2024, 4:00 PM, CST, Glaukos Corp’s stock price was $130.07.

Glaukos Corp is up 6.34% from its previous closing price of $122.31.

During the last market session, Glaukos Corp’s stock traded between $120.37 and $125.06. Currently, there are 50.72 million shares of Glaukos Corp stock available for purchase.

Unfortunately, Glaukos Corp’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Glaukos Corp’s (GKOS) price is currently down 2.85% so far this month.

During the month of September, Glaukos Corp’s stock price has reached a high of $136.61 and a low of $119.54.

Over the last year, Glaukos Corp has hit prices as high as $136.61 and as low as $59.22. Year to date, Glaukos Corp’s stock is up 197.78%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 18, 2024, there were 0 analysts who downgraded Glaukos Corp’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Glaukos Corp’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Glaukos Corp’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Glaukos Corp’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Glaukos Corp (GKOS) by visiting AAII Stock Evaluator.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 18, 2024, Glaukos Corp has a weighted four-quarter relative price strength of 6.44%, which translates to a Momentum Score of 79 and is considered to be Strong.

Want to learn more about how Glaukos Corp is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

As of September 19, 2024, Glaukos Corp’s stock price is $130.07, which is up 6.34% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Glaukos Corp stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.